Skip to content

ACON

Aclarion, Inc.

NASDAQ · USHealthcareMedical - Healthcare Information Services
$2.63+1.94%

Price as of Jul 20, 2026

ACON growth

Aclarion, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+42.6%
EBITDA
-25.5%
EBIT
-49.2%
EPS
+99.8%
Free cash flow
-57.8%
Operating cash flow
-29.5%

Forward estimates

Revenue
+3.4%
EBITDA
+99.0%
EPS
+16.7%

Three-year CAGR

Revenue
+7.8%
EBITDA
-11.8%
EBIT
-27.9%
Net income
-3.4%
EPS
+99.8%
Free cash flow
-28.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.